Overall, these findings suggest that quercetin may have therapeutic potential for treating AD and PD by suppressing the activation of NF-kB and NLRP3 inflammasome, two key inflammatory pathways that contribute to the pathogenesis of the disease [74,82,83]. Here, NFKB1 is linked to Alzheimer disease.